Cathy S. Cutler
Adjunct Professor , Nuclear Engineering Department
Office Address: Research Reactor Center
Research Park Drive
Phone: (573) 882-5211
Fax: (573) 884-7557
Email: CutlerC@missouri.edu
URL: MURR

Education:

1993 PhD Inorganic Chemistry, University of Cincinnati , Cincinnati , OH
1988 BS Biochemistry,University of Cincinnati , Cincinnati , OH

Professional Experience:

2001-present

Senior Research Scientist, University of Missouri Research Reactor, Columbia, MO

2003-present

Adjunct Professor, Nuclear Engineering Department and Nuclear Sciences Engineering Institute, University of Missouri-Columbia

1999-2000

Interim Group Leader, Radiopharmaceuticals Group, University of Missouri Research Reactor

1998-2001 Research Scientist, University of Missouri Research Reactor
1995-1998 Research Associate, Mallinckrodt Institute of Radiology, Washington University Medical School, St. Louis, MO
1993-1995

Postdoctoral Research Assistant, Department of Chemistry, University of Cincinnati, Cincinnati, OH

1988-1993

Graduate Research Assistant, Department of Chemistry, University of Cincinnati, Cincinnati, OH

Recent Publications:
  1. Cutler, C.S.; Engelbrecht, H.P.; Embree, M.F.; Bailey, K.D.; Clark, J.M.; Moustapha, M.; Jurisson, S.S.; Ketring, A.R.; Production of Carrier Free Radioisotopes for Radiotherapy. J Labelled Compd Radiopharm 46 , 44, 2003.

  2. Ketring, A.R.; Ehrhardt, G.J.; Cutler, C.S.; Production and Supply of Radioisotopes for Medical Research at the University of Missouri Research Reactor. J Labelled Compd Radiopharm 46 , 294, 2003.

  3. Lewis, M.R.; Zhang, J.; Jia F.; Owen, N.K.; Cutler, C.S.; Embree, M.F.; Schultz, J.; Theodore, L.J.; Ketring, A.R.; Jurisson, S.S.; Axworthy, D.B.; Biological Comparison of Pm-149, Ho-166, and Lu-177-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice. Nucl. Med. Biol. In press .

  4. Li W.; Smith C.J.; Cutler C.S.; Hoffman T.J.; Ketring A.R.; Jurisson S.S. ; Aminocarboxylate Complexes and Octreotide Complexes with No Carrier Added 177 Lu, 166 Ho, and 149 Pm. Nucl. Med. Biol. 30 , 241-251, 2003.

  5. Ehrhardt, G.J.; Ketring A.R.; Cutler C.S. Radiotherapy Research and Achievements at the University of Missouri Research Reactor. J. of Physics , Accepted June 24, 2002 .

  6. Ketring A.R.; Ehrhardt G.J.; Embree M.F.; Bailey K.D.; Tyler T.T.; Gawenis J.A.; Jurisson S.S.; Engelbrect H.P.; Smith C.J.; and Cutler C.S. ; Production and Supply of High Specific Activity Radioisotopes for Radiotherapy Applications. J. Alasbimn , 5 (19): January 2003.

  7. Hu F.; Cutler C.S.; Hoffman T.; Sieckman G.; Volkert W.A.; Jurisson S.S. ; Pm-149 DOTA Bombesin Analogs for Potential Radiotherapy. In vivo Comparison with Sm-153 and Lu-177 Labeled DO3A-amide- b Ala-BBN(7-14)NH 2 . Nucl. Med. Biol. 29 , 423-430, 2002.

  8. Li W.P.; Ma D.S.; Cutler C.S.; Ketring A.R.; Jurisson S.S. ; Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nucl. Med. Biol. 28 , 145-54, 2001.

  9. Cutler C.S.; Smith C.J.; Tyler T.T.; Jurisson S.S.; Deutsch E.A. ; An Update of Current and Potential Uses of lanthanide Radioisotopes. Cancer Biotherapy and Radiopharmaceuticals 15 (6) 531-545, 2000.

  10. Cutler C.S.; Wuest M.; Anderson C.J.; Reichert D.E.; Yizhen S.; Martell A.E.; and Welch M.J. ; Labeling and In vivo Evaluation of Novel Copper(II) Dioxotetraazamacrocyclic Complexes. Nucl. Med. Biol. 27 , 375-380, 2000.